Last reviewed · How we verify

Hemoblast Bellows application — Competitive Intelligence Brief

Hemoblast Bellows application (Hemoblast Bellows application) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hemostatic agent. Area: Surgery/Hemostasis.

marketed Hemostatic agent Surgery/Hemostasis Small molecule Live · refreshed every 30 min

Target snapshot

Hemoblast Bellows application (Hemoblast Bellows application) — WakeMed Health and Hospitals. Hemoblast Bellows is a hemostatic agent that combines a thrombin-based collagen sponge with a bellows applicator to achieve rapid hemostasis at surgical bleeding sites.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Hemoblast Bellows application TARGET Hemoblast Bellows application WakeMed Health and Hospitals marketed Hemostatic agent
Thrombin JMI Thrombin JMI University of Kansas Medical Center marketed Topical hemostatic agent Fibrinogen
chitosan gel chitosan gel Ain Shams University marketed Biopolymer wound dressing / hemostatic agent
Blood Stopper (Ankaferd) Blood Stopper (Ankaferd) Ankara Ataturk Sanatorium Training and Research Hospital marketed Topical hemostatic agent
Bovine thrombin Bovine thrombin Instituto Grifols, S.A. marketed Coagulation factor / Hemostatic agent Fibrinogen
Fibrinogen + PCC Fibrinogen + PCC University Health Network, Toronto marketed Hemostatic agent / Coagulation factor replacement
Fibrinogen/thrombin-coated collagen patch Fibrinogen/thrombin-coated collagen patch Asan Medical Center marketed Hemostatic agent / Surgical sealant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hemostatic agent class)

  1. Chang Gung Memorial Hospital · 1 drug in this class
  2. DeNova Research · 1 drug in this class
  3. Ethicon, Inc. · 1 drug in this class
  4. Mallinckrodt · 1 drug in this class
  5. Sun Yat-sen University · 1 drug in this class
  6. Swiss Cancer Institute · 1 drug in this class
  7. Takeda · 1 drug in this class
  8. WakeMed Health and Hospitals · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hemoblast Bellows application — Competitive Intelligence Brief. https://druglandscape.com/ci/hemoblast-bellows-application. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: